Apollo Hospitals Enterprise share news, announcements and annual reports
NSE: APOLLOHOSPBSE: 508869Healthcare ServicesLarge Cap
Apollo Hospitals Enterprise Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 1983 on BSE, Jan 1996 on NSE
Last close ₹8,448.00up ₹248.00 (3.02%)BSE ₹8,400.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹8,200.00.
30 Oct: open ₹8,195.00, high ₹8,448.00, low ₹8,176.00
52-week range of traded prices to 30 Oct 2026
₹6,696.50Low, 23 Jan 2026₹9,070.50High, 23 Sep 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,21,469 Cr97th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 58.13
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 12.81
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.24%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 23.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.57
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,72,15658.2% delivered
Apollo Hospitals Enterprise board meetings
141 filed, newest first. Page 3 of 3.
May 2013
10 May · Board meeting
To consider inter alia :- (1) the Audited Financial Results of the Company for the quarter/year ended March 31, 2013; (2) the Audited Consolidated Financial Results of the Company and its subsidiaries, Joint Ventures and Associate Companies for the year ended March 31, 2013; (3) to recommend a dividend, if any, for the financial year ended March 31, 2013.
Jan 2013
21 Jan · Board meeting
To consider inter alia, approve and take on record unaudited financial results of the Company for the quarter/nine months ended December 31, 2012.
Nov 2012
9 Nov · Board meeting
Board of Directors of the Company at its meeting held on November 09, 2012 has taken the following decisions : (1) Noted the resignation of Mr. Sandeep Naik as a director (Nominee of HSTN Acquisition (FII) Limited) of the Company; (2) Approved the appointment of Mr. Shashank Singh as an additional director (Nominee of HSTN Acquisition (FII) Limited) of the Company; (3) Noted the resignation of Mr. Michael Fernandes as an alternate director to Mr.Khairil Anuar Abdullah.
Oct 2012
16 Oct · Board meeting
To consider inter alia, approve and take on record unaudited financial results of the Company for the quarter/half year ended September 30, 2012.
Jul 2012
20 Jul · Board meeting
To consider inter-alia, approve and take on record unaudited financial results of the company for the quarter ended June 30, 2012.
May 2012
14 May · Board meeting
To consider inter alia :- (1) The Audited Financial Results of the Company for the year ended March 31, 2012; (2) The Audited Consolidated Financial Results of the Company and its subsidiaries, Joint Ventures and Associate Companies for the year ended March 31, 2012; (3) To recommend a dividend, if any, for the financial year ended March 31, 2012.
Jan 2012
19 Jan · Board meeting
To consider inter alia, approve and take on record unaudited financial results of the Company for the quarter/nine months ended December 31, 2011.
Dec 2011
9 Dec · Board meeting
Pursuant to the approval of members at the Extraordinary General Meeting held on May 29, 2010, the Company had issued and allotted 1,544,621 share warrants to Dr. Prathap C Reddy, one of the promoters of the Company on June 12, 2010, with each warrant convertible into one equity share of the Company of nominal value of Rs.10/- each at a price of Rs.771.76 which includes premium of Rs.761.76 per share calculated in accordance with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2009. The said warrants shall be convertible into equity shares within a period of 18 months from the date of allotment of warrants i.e., on or before December 11, 2011.The Company obtained the members approval for effecting a stock split in the face value of the equity shares from Rs.10/- each to Rs.5/- each. The stock split was effected from September 03, 2010 onwards. Pursuant to the terms of the issue, 1,544,621 warrants allotted to Dr. Prathap C Reddy and the corresponding issue price of Rs.771.76 shall stand adjusted accordingly as 3,089,242 warrants of face value of Rs.5/- each at a price of Rs.385.88 including premium of Rs.380.88 per share. Further note that the Meeting of the Share Allotment Committee is scheduled to be held on December 10, 2011, to approve, issue and allot 3,089,242 equity shares of Rs.5/- each at a price of Rs. 385.88 per share to Dr. Prathap C Reddy, promoter of the company, upon conversion of share warrants allotted to him on June 12, 2010.
Oct 2011
17 Oct · Board meeting
Inter alia, to consider, approve and take on record unaudited financial results of the Company for the quarter and half year ended September 30, 2011.
Jul 2011
26 Jul · Board meeting
Inter alia, to consider, approve and take on record unaudited financial results of the Company for the quarter ended June 30, 2011.
May 2011
26 May · Board meeting
Based on the recommendation of the Remuneration & Nomination Committee, the Board at its meeting held on May 24, 2011 approved the re-designation of Ms. Suneeta Reddy as Joint Managing Director with effect from June 01, 2011 on a remuneration of 1.50% of the net profits of the Company (for the period from June 01, 2011 to February 02, 2016) subject to approval of the members at the ensuing Annual General Meeting.11 May · Board meeting
To consider inter alia :- (1)The Audited Financial Results of the Company for the year ended March 31, 2011; (2) The Audited Consolidated Financial Results of the Company and its subsidiaries, Joint Ventures and Associate Companies for the year ended March 31, 2011; (3) To recommend a dividend, if any, for the financial year ended March 31, 2011.
Feb 2011
5 Feb · Board meeting
Committee is meeting on February 5, 2011 to consider and approve the allotment of 3,276,922 warrants convertible into equity shares to Dr. Prathap C Reddy pursuant to the special resolution approved by the members at the EGM held on January 22, 2011.
Jan 2011
24 Jan · Board meeting
Inter alia, to consider, approve and take on record unaudited financial results of the Company for the quarter / nine months ended December 31, 2010.
Dec 2010
7 Dec · Board meeting
To consider allotment of 1,140,992 equity shares to the International Finance Corporation, Washington DC at a price of Rs. 302.50 per equity share of Rs. 5/- each upon part conversion of FCCB loan amount of USD 7.5 million.
Oct 2010
20 Oct · Board meeting
Inter alia, to consider, approve and take on record unaudited financial results of the Company for the quarter / half year ended September 30, 2010.
Jul 2010
28 Jul · Board meeting
Inter alia, to consider, approve and take on record the unaudited financial results of the Company for the quarter ended June 30, 2010.
Jun 2010
10 Jun · Board meeting
Committee is meeting on June 12, 2010 to consider and approve the allotment of 1,544,621 warrants convertible into equity shares to Dr. Prathap C Reddy pursuant to the special resolution approved by the members at the EGM held on May 29, 2010.
May 2010
12 May · Board meeting
To consider inter alia:- (1)The Audited Financial Results of the Company for the year ended March 31, 2010. (2) The Audited Consolidated Financial Results of the Company and its subsidiaries, Joint Ventures and Associate Companies for the year ended March 31, 2010. (3) To recommend a dividend, if any, for the financial year ended March 31, 2010.
Jan 2010
28 Jan · Board meeting
Board of Directors at its meeting held on January 28, 2010 has taken the following decisions. (1) Approved the appointment of Ms. Shobana Kamineni as an Additional Director and Whole Time Director designated as Executive Director of the Company with effect from February 01, 2010, subject to approval of members. (2) Approved the allotment of 1500 Unsecured Foreign Currency Convertible Bonds (FCCB) of face value of USD 10,000 each aggregating to US$ 15,000,000 with an option of convertible into equity shares at a price of Rs.605/- per share. The Board took on record the ill health of Mr. P. Obul Reddy and consequently his inability to continue as a Director.12 Jan · Board meeting
Inter alia, to consider, approve and take on record unaudited financial results of the Company for the quarter / nine months ended December 31, 2009.
Oct 2009
14 Oct · Board meeting
Inter alia, to consider, approve the unaudited financial results of the Company for the quarter / half year ended September 30, 2009.
Jul 2009
7 Jul · Board meeting
Meeting on 18 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”
Jun 2009
19 Jun · Board meeting
To consider inter alia:- (i) the Audited Financial Results of the Company for the year ended March 31, 2009. (ii) the Audited Consolidated Financial Results of the Company and its subsidiaries, Joint Ventures and Associate Companies for the year ended March 31, 2009. (iii) to recommend a dividend, if any, for the financial year ended March 31, 2009.
Apr 2009
20 Apr · Board meeting
Committee of Board of Directors at its meeting held on April 18, 2009 approved the allotment of 1,549,157 equity shares of face value of Rs. 10/- each at a price of Rs. 497.69 per share to Dr. Prathap C Reddy, promoter of the Company. Consequent to the above allotment, the paid up share capital of the company has been increased to Rs. 617,848,590/- (consisting of 61,784,859 equity shares of Rs.10/- each) from Rs. 602,357,020/- (consisting of 60,235,702 equity shares of Rs.10/- each).17 Apr · Board meeting
Meeting of the Committee is scheduled to be held on April 18, 2009, to approve issue and allot 1,549,157 equity shares of Rs. 10/- each at a price of Rs. 497.69 per share to Dr. Prathap C Reddy, promoter of the Company upon conversion of 1,549,157 share warrants alloted to him on October 19, 2007.
Jan 2009
15 Jan · Board meeting
Inter alia, to consider, approve and take on record unaudited financial results of the Company for the quarter/nine months ended December 31, 2008.
Oct 2008
17 Oct · Board meeting
Inter alia, to consider, approve the following:- (1) unaudited financial results of the Company for the quarter/ half year ended September 30, 2008. (2) Sub-division (Split) of equity shares of the Company and other matters connected therewith.
Aug 2008
20 Aug · Board meeting
Meeting of the Committee is scheduled to be held on August 22, 2008, to approve, issue and allot 1,550,000 equity shares of Rs. 10/- each at a price of Rs. 442.55 per share to Ms. Sangita Reddy, one of the promoters of the company upon conversion of 1,550,000 share warrants allotted to her on February 23, 2007.
Jul 2008
17 Jul · Board meeting
Meeting on 31 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”
Jun 2008
24 Jun · Board meeting
Board of Directors at its meeting held on June 24, 2008 has taken the following decisions: Approved in-principle for issue of :- a) Warrants not exceeding 58,68,000 convertible into equity shares to the Promoters/Promoter group. b) 758,000 equity shares/warrants convertible into equity shares to Apax Mauritius FDI One Limited. c) Authorised the committee to decide on the actual No. of warrants and equity shares and the timing for issue of the same in accordance with the then existing SEBI guidelines and other applicable regulations.9 Jun · Board meeting
To consider inter alia:- (i) the Audited Financial Results of the Company for the year ended March 31, 2008. (ii) the Audited Consolidated Financial Results of the Company and its subsidiaries, Joint Ventures and Associate Companies for the year ended March 31, 2008. (iii) to recommend a dividend, if any, for the financial year ended March 31, 2008.
Jan 2008
9 Jan · Board meeting
Inter alia, to consider, approve and take on record unaudited financial results of the Company for the quarter/nine months ended December 31, 2007.
Oct 2007
12 Oct · Board meeting
Meeting on 23 Oct 2007: “Unaudited Results for Qtr & Half year ended Sep 30, 2007”
Jul 2007
11 Jul · Board meeting
Meeting on 23 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”
Jun 2007
11 Jun · Board meeting
To consider Inter alia :- (i) the Audited Financial Results of the Company for the year ended March 31, 2007. (ii) the Audited Consolidated Financial Results of the Company and its subsidiaries, Joint Ventures and Associate Companies for the year ended March 31, 2007. (iii) to recommend a final dividend, if any, for the financial year ended March 31, 2007.
Mar 2007
9 Mar · Board meeting
To consider inter alia, the declaration of Interim Dividend for the year 2006-07. Further, the Company has fixed March 24, 2007 as the Record date for the purpose of payment of said Interim Dividend, if declared and the payout of the said Interim Dividend, if declared, will be on and from March 30, 2007.
Feb 2007
21 Feb · Board meeting
Committee is meeting on Friday, 23rd February, 2007 to approve the allotment of 1,550,000 warrants to Ms. Sangita Reddy pursuant to the special resolution approved by the members at the EGM held on 9th February, 2007.
Jan 2007
24 Jan · Board meeting
January 24, 2007 that "the Board of Directors at its meeting held today approved the following :- (i) Audited Consolidated Financial Results of the Company and its Subsidiaries, Joint Ventures and Associate Companies for the half year ended September 30, 2006. (ii) Unaudited Non-Consolidated Financial Results of the Company for the quarter/nine months ended December 31, 2006. (iii) Authorizing Dr. Prathap C Reddy, Chairman to sign the Shareholders/Joint Venture Agreement with One Equity Partner LLC (OEP), a private equity investment company, incorporated under the laws of Delaware, USA for setting up of hospital at Mumbai".16 Jan · Board meeting
To consider inter alia, approve and take on record :- (i) Audited consolidated financial results of the Company and its subsidiaries, Joint Ventures and Associate Companies for the half year ended September 30, 2006. (ii) Unaudited non-consolidated financial results of the Company for the quarter/nine months ended December 31, 2006 and the same shall be published on or before January 26, 2007.